INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2157282, encodeId=3631215e28241, content=偏重的研究方向：生物信息学;分子医学 经验分享：9.8投了篇纯生信，，，还是p e n d in g r ev i e w，要拒也麻烦快一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29968843690, createdName=ms4000000352004046, createdTime=Tue Sep 12 10:48:42 CST 2023, time=2023-09-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2262340, encodeId=1d80226234078, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤生信分析 经验分享：现在pending的时间是变长了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0578477592, createdName=ms7000000921712169, createdTime=Sat Apr 26 10:41:59 CST 2025, time=2025-04-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2288854, encodeId=0a242288854a5, content=中科院分区再这上面是2区top 再letpub上面是3区差的有点大啊哪个准确啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6bd22035102, createdName=六月的雨, createdTime=Fri Nov 14 10:55:31 CST 2025, time=2025-11-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2287414, encodeId=2c55228e4149a, content=请问WB按分子量裁开分别敷抗体然后拼接在一起，这样可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeea9862050, createdName=ms8000001548862053, createdTime=Tue Nov 04 08:47:56 CST 2025, time=2025-11-04, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2280825, encodeId=bf4722808259e, content=我投稿第二天就Pending editor decision，是不是要拒了，医院的，但是基本纯实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37235317227, createdName=1489e359m96(暂无昵称), createdTime=Thu Sep 11 08:15:35 CST 2025, time=2025-09-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2244137, encodeId=26d3224413e92, content=挺好的杂志，审稿很认真，也没有预警，值得一投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa371702984, createdName=malonglee, createdTime=Sat Dec 21 20:15:04 CST 2024, time=2024-12-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2235629, encodeId=2f592235629c7, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：速度挺快的，着急毕业的可以了解一下这个期刊。 7.29投稿 8.13给了一审意见 后面又修改了3次 10月5接收 耗时两个月多一点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822132, createdTime=Wed Nov 06 23:52:06 CST 2024, time=2024-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2259467, encodeId=a53c225946e16, content=偏重的研究方向：转化 经验分享：4月上旬投稿，记录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/392EF952E79DBD31432C86E1D99AF01C/100, createdBy=03d22194782, createdName=lssmd, createdTime=Mon Apr 07 17:21:28 CST 2025, time=2025-04-07, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2122268, encodeId=fb1f212226849, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：miRNA;生化 经验分享：我3.27提交大修返修稿在MDPI系统里一直提交不了，3.28号今天是最后一天，今天试了还是提交不了，我是7号收到的大修，给了10天，我申请延期至28号，编辑也同意了，昨天早上收到催我返修的邮件，昨天下午五点左右就开始尝试提交资料和返修稿子，但一直网站显示不行，不是网络的问题，也不是电脑的问题，真的傻了，现在还是提交不了，不知道咋整了，一直显示网站错误，我已经回复审稿人的意见和将我的修改的手稿和相关补充材料发给了编辑，和编辑说明了这个情况，希望编辑能够帮我将修改稿和相关资料发给审稿人，这样可以吗？因为暂时没有收到编辑的回复，有点担心⊙﹏⊙‖大家有遇到这样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b77e8515511, createdName=slbyzrbf, createdTime=Tue Mar 28 13:36:40 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2272906, encodeId=8f5422e290697, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：重金属的神经毒性;生信分析 经验分享：收稿日期 19 六月 2025 修订日期 7 七月 2025 录用日期 9 七月 2025 提交第一次决定（天） 18 提交发布（天） 修订轮次 1 这两天刚接收，编辑很积极，会经常发邮件提醒，节奏也很快，有2个审稿人，只有一次小修，总体很顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63949468110, createdName=ms7000000807282110, createdTime=Fri Jul 11 10:22:40 CST 2025, time=2025-07-11, status=1, ipAttribution=陕西省)]

2023-09-12 ms4000000352004046 来自江苏省

偏重的研究方向：生物信息学;分子医学
经验分享：9.8投了篇纯生信，，，还是p e n d in g r ev i e w，要拒也麻烦快一点啊

123 5 举报

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157282, encodeId=3631215e28241, content=偏重的研究方向：生物信息学;分子医学 经验分享：9.8投了篇纯生信，，，还是p e n d in g r ev i e w，要拒也麻烦快一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29968843690, createdName=ms4000000352004046, createdTime=Tue Sep 12 10:48:42 CST 2023, time=2023-09-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2262340, encodeId=1d80226234078, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤生信分析 经验分享：现在pending的时间是变长了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0578477592, createdName=ms7000000921712169, createdTime=Sat Apr 26 10:41:59 CST 2025, time=2025-04-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2288854, encodeId=0a242288854a5, content=中科院分区再这上面是2区top 再letpub上面是3区差的有点大啊哪个准确啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6bd22035102, createdName=六月的雨, createdTime=Fri Nov 14 10:55:31 CST 2025, time=2025-11-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2287414, encodeId=2c55228e4149a, content=请问WB按分子量裁开分别敷抗体然后拼接在一起，这样可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeea9862050, createdName=ms8000001548862053, createdTime=Tue Nov 04 08:47:56 CST 2025, time=2025-11-04, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2280825, encodeId=bf4722808259e, content=我投稿第二天就Pending editor decision，是不是要拒了，医院的，但是基本纯实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37235317227, createdName=1489e359m96(暂无昵称), createdTime=Thu Sep 11 08:15:35 CST 2025, time=2025-09-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2244137, encodeId=26d3224413e92, content=挺好的杂志，审稿很认真，也没有预警，值得一投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa371702984, createdName=malonglee, createdTime=Sat Dec 21 20:15:04 CST 2024, time=2024-12-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2235629, encodeId=2f592235629c7, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：速度挺快的，着急毕业的可以了解一下这个期刊。 7.29投稿 8.13给了一审意见 后面又修改了3次 10月5接收 耗时两个月多一点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822132, createdTime=Wed Nov 06 23:52:06 CST 2024, time=2024-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2259467, encodeId=a53c225946e16, content=偏重的研究方向：转化 经验分享：4月上旬投稿，记录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/392EF952E79DBD31432C86E1D99AF01C/100, createdBy=03d22194782, createdName=lssmd, createdTime=Mon Apr 07 17:21:28 CST 2025, time=2025-04-07, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2122268, encodeId=fb1f212226849, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：miRNA;生化 经验分享：我3.27提交大修返修稿在MDPI系统里一直提交不了，3.28号今天是最后一天，今天试了还是提交不了，我是7号收到的大修，给了10天，我申请延期至28号，编辑也同意了，昨天早上收到催我返修的邮件，昨天下午五点左右就开始尝试提交资料和返修稿子，但一直网站显示不行，不是网络的问题，也不是电脑的问题，真的傻了，现在还是提交不了，不知道咋整了，一直显示网站错误，我已经回复审稿人的意见和将我的修改的手稿和相关补充材料发给了编辑，和编辑说明了这个情况，希望编辑能够帮我将修改稿和相关资料发给审稿人，这样可以吗？因为暂时没有收到编辑的回复，有点担心⊙﹏⊙‖大家有遇到这样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b77e8515511, createdName=slbyzrbf, createdTime=Tue Mar 28 13:36:40 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2272906, encodeId=8f5422e290697, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：重金属的神经毒性;生信分析 经验分享：收稿日期 19 六月 2025 修订日期 7 七月 2025 录用日期 9 七月 2025 提交第一次决定（天） 18 提交发布（天） 修订轮次 1 这两天刚接收，编辑很积极，会经常发邮件提醒，节奏也很快，有2个审稿人，只有一次小修，总体很顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63949468110, createdName=ms7000000807282110, createdTime=Fri Jul 11 10:22:40 CST 2025, time=2025-07-11, status=1, ipAttribution=陕西省)]

2025-04-26 ms7000000921712169 来自广东省

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤生信分析
经验分享：现在pending的时间是变长了吗

82 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157282, encodeId=3631215e28241, content=偏重的研究方向：生物信息学;分子医学 经验分享：9.8投了篇纯生信，，，还是p e n d in g r ev i e w，要拒也麻烦快一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29968843690, createdName=ms4000000352004046, createdTime=Tue Sep 12 10:48:42 CST 2023, time=2023-09-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2262340, encodeId=1d80226234078, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤生信分析 经验分享：现在pending的时间是变长了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0578477592, createdName=ms7000000921712169, createdTime=Sat Apr 26 10:41:59 CST 2025, time=2025-04-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2288854, encodeId=0a242288854a5, content=中科院分区再这上面是2区top 再letpub上面是3区差的有点大啊哪个准确啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6bd22035102, createdName=六月的雨, createdTime=Fri Nov 14 10:55:31 CST 2025, time=2025-11-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2287414, encodeId=2c55228e4149a, content=请问WB按分子量裁开分别敷抗体然后拼接在一起，这样可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeea9862050, createdName=ms8000001548862053, createdTime=Tue Nov 04 08:47:56 CST 2025, time=2025-11-04, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2280825, encodeId=bf4722808259e, content=我投稿第二天就Pending editor decision，是不是要拒了，医院的，但是基本纯实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37235317227, createdName=1489e359m96(暂无昵称), createdTime=Thu Sep 11 08:15:35 CST 2025, time=2025-09-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2244137, encodeId=26d3224413e92, content=挺好的杂志，审稿很认真，也没有预警，值得一投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa371702984, createdName=malonglee, createdTime=Sat Dec 21 20:15:04 CST 2024, time=2024-12-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2235629, encodeId=2f592235629c7, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：速度挺快的，着急毕业的可以了解一下这个期刊。 7.29投稿 8.13给了一审意见 后面又修改了3次 10月5接收 耗时两个月多一点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822132, createdTime=Wed Nov 06 23:52:06 CST 2024, time=2024-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2259467, encodeId=a53c225946e16, content=偏重的研究方向：转化 经验分享：4月上旬投稿，记录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/392EF952E79DBD31432C86E1D99AF01C/100, createdBy=03d22194782, createdName=lssmd, createdTime=Mon Apr 07 17:21:28 CST 2025, time=2025-04-07, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2122268, encodeId=fb1f212226849, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：miRNA;生化 经验分享：我3.27提交大修返修稿在MDPI系统里一直提交不了，3.28号今天是最后一天，今天试了还是提交不了，我是7号收到的大修，给了10天，我申请延期至28号，编辑也同意了，昨天早上收到催我返修的邮件，昨天下午五点左右就开始尝试提交资料和返修稿子，但一直网站显示不行，不是网络的问题，也不是电脑的问题，真的傻了，现在还是提交不了，不知道咋整了，一直显示网站错误，我已经回复审稿人的意见和将我的修改的手稿和相关补充材料发给了编辑，和编辑说明了这个情况，希望编辑能够帮我将修改稿和相关资料发给审稿人，这样可以吗？因为暂时没有收到编辑的回复，有点担心⊙﹏⊙‖大家有遇到这样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b77e8515511, createdName=slbyzrbf, createdTime=Tue Mar 28 13:36:40 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2272906, encodeId=8f5422e290697, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：重金属的神经毒性;生信分析 经验分享：收稿日期 19 六月 2025 修订日期 7 七月 2025 录用日期 9 七月 2025 提交第一次决定（天） 18 提交发布（天） 修订轮次 1 这两天刚接收，编辑很积极，会经常发邮件提醒，节奏也很快，有2个审稿人，只有一次小修，总体很顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63949468110, createdName=ms7000000807282110, createdTime=Fri Jul 11 10:22:40 CST 2025, time=2025-07-11, status=1, ipAttribution=陕西省)]

2025-11-14 六月的雨来自上海

中科院分区再这上面是2区top 再letpub上面是3区差的有点大啊哪个准确啊

9 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2157282, encodeId=3631215e28241, content=偏重的研究方向：生物信息学;分子医学 经验分享：9.8投了篇纯生信，，，还是p e n d in g r ev i e w，要拒也麻烦快一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29968843690, createdName=ms4000000352004046, createdTime=Tue Sep 12 10:48:42 CST 2023, time=2023-09-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2262340, encodeId=1d80226234078, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤生信分析 经验分享：现在pending的时间是变长了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0578477592, createdName=ms7000000921712169, createdTime=Sat Apr 26 10:41:59 CST 2025, time=2025-04-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2288854, encodeId=0a242288854a5, content=中科院分区再这上面是2区top 再letpub上面是3区差的有点大啊哪个准确啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6bd22035102, createdName=六月的雨, createdTime=Fri Nov 14 10:55:31 CST 2025, time=2025-11-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2287414, encodeId=2c55228e4149a, content=请问WB按分子量裁开分别敷抗体然后拼接在一起，这样可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeea9862050, createdName=ms8000001548862053, createdTime=Tue Nov 04 08:47:56 CST 2025, time=2025-11-04, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2280825, encodeId=bf4722808259e, content=我投稿第二天就Pending editor decision，是不是要拒了，医院的，但是基本纯实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37235317227, createdName=1489e359m96(暂无昵称), createdTime=Thu Sep 11 08:15:35 CST 2025, time=2025-09-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2244137, encodeId=26d3224413e92, content=挺好的杂志，审稿很认真，也没有预警，值得一投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa371702984, createdName=malonglee, createdTime=Sat Dec 21 20:15:04 CST 2024, time=2024-12-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2235629, encodeId=2f592235629c7, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：速度挺快的，着急毕业的可以了解一下这个期刊。 7.29投稿 8.13给了一审意见 后面又修改了3次 10月5接收 耗时两个月多一点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822132, createdTime=Wed Nov 06 23:52:06 CST 2024, time=2024-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2259467, encodeId=a53c225946e16, content=偏重的研究方向：转化 经验分享：4月上旬投稿，记录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/392EF952E79DBD31432C86E1D99AF01C/100, createdBy=03d22194782, createdName=lssmd, createdTime=Mon Apr 07 17:21:28 CST 2025, time=2025-04-07, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2122268, encodeId=fb1f212226849, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：miRNA;生化 经验分享：我3.27提交大修返修稿在MDPI系统里一直提交不了，3.28号今天是最后一天，今天试了还是提交不了，我是7号收到的大修，给了10天，我申请延期至28号，编辑也同意了，昨天早上收到催我返修的邮件，昨天下午五点左右就开始尝试提交资料和返修稿子，但一直网站显示不行，不是网络的问题，也不是电脑的问题，真的傻了，现在还是提交不了，不知道咋整了，一直显示网站错误，我已经回复审稿人的意见和将我的修改的手稿和相关补充材料发给了编辑，和编辑说明了这个情况，希望编辑能够帮我将修改稿和相关资料发给审稿人，这样可以吗？因为暂时没有收到编辑的回复，有点担心⊙﹏⊙‖大家有遇到这样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b77e8515511, createdName=slbyzrbf, createdTime=Tue Mar 28 13:36:40 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2272906, encodeId=8f5422e290697, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：重金属的神经毒性;生信分析 经验分享：收稿日期 19 六月 2025 修订日期 7 七月 2025 录用日期 9 七月 2025 提交第一次决定（天） 18 提交发布（天） 修订轮次 1 这两天刚接收，编辑很积极，会经常发邮件提醒，节奏也很快，有2个审稿人，只有一次小修，总体很顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63949468110, createdName=ms7000000807282110, createdTime=Fri Jul 11 10:22:40 CST 2025, time=2025-07-11, status=1, ipAttribution=陕西省)]

2025-11-04 ms8000001548862053 来自山西省

请问WB按分子量裁开分别敷抗体然后拼接在一起，这样可以吗

17 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2157282, encodeId=3631215e28241, content=偏重的研究方向：生物信息学;分子医学 经验分享：9.8投了篇纯生信，，，还是p e n d in g r ev i e w，要拒也麻烦快一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29968843690, createdName=ms4000000352004046, createdTime=Tue Sep 12 10:48:42 CST 2023, time=2023-09-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2262340, encodeId=1d80226234078, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤生信分析 经验分享：现在pending的时间是变长了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0578477592, createdName=ms7000000921712169, createdTime=Sat Apr 26 10:41:59 CST 2025, time=2025-04-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2288854, encodeId=0a242288854a5, content=中科院分区再这上面是2区top 再letpub上面是3区差的有点大啊哪个准确啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6bd22035102, createdName=六月的雨, createdTime=Fri Nov 14 10:55:31 CST 2025, time=2025-11-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2287414, encodeId=2c55228e4149a, content=请问WB按分子量裁开分别敷抗体然后拼接在一起，这样可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeea9862050, createdName=ms8000001548862053, createdTime=Tue Nov 04 08:47:56 CST 2025, time=2025-11-04, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2280825, encodeId=bf4722808259e, content=我投稿第二天就Pending editor decision，是不是要拒了，医院的，但是基本纯实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37235317227, createdName=1489e359m96(暂无昵称), createdTime=Thu Sep 11 08:15:35 CST 2025, time=2025-09-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2244137, encodeId=26d3224413e92, content=挺好的杂志，审稿很认真，也没有预警，值得一投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa371702984, createdName=malonglee, createdTime=Sat Dec 21 20:15:04 CST 2024, time=2024-12-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2235629, encodeId=2f592235629c7, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：速度挺快的，着急毕业的可以了解一下这个期刊。 7.29投稿 8.13给了一审意见 后面又修改了3次 10月5接收 耗时两个月多一点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822132, createdTime=Wed Nov 06 23:52:06 CST 2024, time=2024-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2259467, encodeId=a53c225946e16, content=偏重的研究方向：转化 经验分享：4月上旬投稿，记录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/392EF952E79DBD31432C86E1D99AF01C/100, createdBy=03d22194782, createdName=lssmd, createdTime=Mon Apr 07 17:21:28 CST 2025, time=2025-04-07, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2122268, encodeId=fb1f212226849, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：miRNA;生化 经验分享：我3.27提交大修返修稿在MDPI系统里一直提交不了，3.28号今天是最后一天，今天试了还是提交不了，我是7号收到的大修，给了10天，我申请延期至28号，编辑也同意了，昨天早上收到催我返修的邮件，昨天下午五点左右就开始尝试提交资料和返修稿子，但一直网站显示不行，不是网络的问题，也不是电脑的问题，真的傻了，现在还是提交不了，不知道咋整了，一直显示网站错误，我已经回复审稿人的意见和将我的修改的手稿和相关补充材料发给了编辑，和编辑说明了这个情况，希望编辑能够帮我将修改稿和相关资料发给审稿人，这样可以吗？因为暂时没有收到编辑的回复，有点担心⊙﹏⊙‖大家有遇到这样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b77e8515511, createdName=slbyzrbf, createdTime=Tue Mar 28 13:36:40 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2272906, encodeId=8f5422e290697, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：重金属的神经毒性;生信分析 经验分享：收稿日期 19 六月 2025 修订日期 7 七月 2025 录用日期 9 七月 2025 提交第一次决定（天） 18 提交发布（天） 修订轮次 1 这两天刚接收，编辑很积极，会经常发邮件提醒，节奏也很快，有2个审稿人，只有一次小修，总体很顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63949468110, createdName=ms7000000807282110, createdTime=Fri Jul 11 10:22:40 CST 2025, time=2025-07-11, status=1, ipAttribution=陕西省)]

2025-09-11 1489e359m96(暂无昵称) 来自广东省

我投稿第二天就Pending editor decision，是不是要拒了，医院的，但是基本纯实验

51 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157282, encodeId=3631215e28241, content=偏重的研究方向：生物信息学;分子医学 经验分享：9.8投了篇纯生信，，，还是p e n d in g r ev i e w，要拒也麻烦快一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29968843690, createdName=ms4000000352004046, createdTime=Tue Sep 12 10:48:42 CST 2023, time=2023-09-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2262340, encodeId=1d80226234078, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤生信分析 经验分享：现在pending的时间是变长了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0578477592, createdName=ms7000000921712169, createdTime=Sat Apr 26 10:41:59 CST 2025, time=2025-04-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2288854, encodeId=0a242288854a5, content=中科院分区再这上面是2区top 再letpub上面是3区差的有点大啊哪个准确啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6bd22035102, createdName=六月的雨, createdTime=Fri Nov 14 10:55:31 CST 2025, time=2025-11-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2287414, encodeId=2c55228e4149a, content=请问WB按分子量裁开分别敷抗体然后拼接在一起，这样可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeea9862050, createdName=ms8000001548862053, createdTime=Tue Nov 04 08:47:56 CST 2025, time=2025-11-04, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2280825, encodeId=bf4722808259e, content=我投稿第二天就Pending editor decision，是不是要拒了，医院的，但是基本纯实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37235317227, createdName=1489e359m96(暂无昵称), createdTime=Thu Sep 11 08:15:35 CST 2025, time=2025-09-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2244137, encodeId=26d3224413e92, content=挺好的杂志，审稿很认真，也没有预警，值得一投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa371702984, createdName=malonglee, createdTime=Sat Dec 21 20:15:04 CST 2024, time=2024-12-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2235629, encodeId=2f592235629c7, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：速度挺快的，着急毕业的可以了解一下这个期刊。 7.29投稿 8.13给了一审意见 后面又修改了3次 10月5接收 耗时两个月多一点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822132, createdTime=Wed Nov 06 23:52:06 CST 2024, time=2024-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2259467, encodeId=a53c225946e16, content=偏重的研究方向：转化 经验分享：4月上旬投稿，记录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/392EF952E79DBD31432C86E1D99AF01C/100, createdBy=03d22194782, createdName=lssmd, createdTime=Mon Apr 07 17:21:28 CST 2025, time=2025-04-07, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2122268, encodeId=fb1f212226849, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：miRNA;生化 经验分享：我3.27提交大修返修稿在MDPI系统里一直提交不了，3.28号今天是最后一天，今天试了还是提交不了，我是7号收到的大修，给了10天，我申请延期至28号，编辑也同意了，昨天早上收到催我返修的邮件，昨天下午五点左右就开始尝试提交资料和返修稿子，但一直网站显示不行，不是网络的问题，也不是电脑的问题，真的傻了，现在还是提交不了，不知道咋整了，一直显示网站错误，我已经回复审稿人的意见和将我的修改的手稿和相关补充材料发给了编辑，和编辑说明了这个情况，希望编辑能够帮我将修改稿和相关资料发给审稿人，这样可以吗？因为暂时没有收到编辑的回复，有点担心⊙﹏⊙‖大家有遇到这样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b77e8515511, createdName=slbyzrbf, createdTime=Tue Mar 28 13:36:40 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2272906, encodeId=8f5422e290697, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：重金属的神经毒性;生信分析 经验分享：收稿日期 19 六月 2025 修订日期 7 七月 2025 录用日期 9 七月 2025 提交第一次决定（天） 18 提交发布（天） 修订轮次 1 这两天刚接收，编辑很积极，会经常发邮件提醒，节奏也很快，有2个审稿人，只有一次小修，总体很顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63949468110, createdName=ms7000000807282110, createdTime=Fri Jul 11 10:22:40 CST 2025, time=2025-07-11, status=1, ipAttribution=陕西省)]

2024-12-21 malonglee 来自上海

挺好的杂志，审稿很认真，也没有预警，值得一投

92 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157282, encodeId=3631215e28241, content=偏重的研究方向：生物信息学;分子医学 经验分享：9.8投了篇纯生信，，，还是p e n d in g r ev i e w，要拒也麻烦快一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29968843690, createdName=ms4000000352004046, createdTime=Tue Sep 12 10:48:42 CST 2023, time=2023-09-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2262340, encodeId=1d80226234078, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤生信分析 经验分享：现在pending的时间是变长了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0578477592, createdName=ms7000000921712169, createdTime=Sat Apr 26 10:41:59 CST 2025, time=2025-04-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2288854, encodeId=0a242288854a5, content=中科院分区再这上面是2区top 再letpub上面是3区差的有点大啊哪个准确啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6bd22035102, createdName=六月的雨, createdTime=Fri Nov 14 10:55:31 CST 2025, time=2025-11-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2287414, encodeId=2c55228e4149a, content=请问WB按分子量裁开分别敷抗体然后拼接在一起，这样可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeea9862050, createdName=ms8000001548862053, createdTime=Tue Nov 04 08:47:56 CST 2025, time=2025-11-04, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2280825, encodeId=bf4722808259e, content=我投稿第二天就Pending editor decision，是不是要拒了，医院的，但是基本纯实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37235317227, createdName=1489e359m96(暂无昵称), createdTime=Thu Sep 11 08:15:35 CST 2025, time=2025-09-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2244137, encodeId=26d3224413e92, content=挺好的杂志，审稿很认真，也没有预警，值得一投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa371702984, createdName=malonglee, createdTime=Sat Dec 21 20:15:04 CST 2024, time=2024-12-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2235629, encodeId=2f592235629c7, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：速度挺快的，着急毕业的可以了解一下这个期刊。 7.29投稿 8.13给了一审意见 后面又修改了3次 10月5接收 耗时两个月多一点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822132, createdTime=Wed Nov 06 23:52:06 CST 2024, time=2024-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2259467, encodeId=a53c225946e16, content=偏重的研究方向：转化 经验分享：4月上旬投稿，记录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/392EF952E79DBD31432C86E1D99AF01C/100, createdBy=03d22194782, createdName=lssmd, createdTime=Mon Apr 07 17:21:28 CST 2025, time=2025-04-07, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2122268, encodeId=fb1f212226849, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：miRNA;生化 经验分享：我3.27提交大修返修稿在MDPI系统里一直提交不了，3.28号今天是最后一天，今天试了还是提交不了，我是7号收到的大修，给了10天，我申请延期至28号，编辑也同意了，昨天早上收到催我返修的邮件，昨天下午五点左右就开始尝试提交资料和返修稿子，但一直网站显示不行，不是网络的问题，也不是电脑的问题，真的傻了，现在还是提交不了，不知道咋整了，一直显示网站错误，我已经回复审稿人的意见和将我的修改的手稿和相关补充材料发给了编辑，和编辑说明了这个情况，希望编辑能够帮我将修改稿和相关资料发给审稿人，这样可以吗？因为暂时没有收到编辑的回复，有点担心⊙﹏⊙‖大家有遇到这样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b77e8515511, createdName=slbyzrbf, createdTime=Tue Mar 28 13:36:40 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2272906, encodeId=8f5422e290697, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：重金属的神经毒性;生信分析 经验分享：收稿日期 19 六月 2025 修订日期 7 七月 2025 录用日期 9 七月 2025 提交第一次决定（天） 18 提交发布（天） 修订轮次 1 这两天刚接收，编辑很积极，会经常发邮件提醒，节奏也很快，有2个审稿人，只有一次小修，总体很顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63949468110, createdName=ms7000000807282110, createdTime=Fri Jul 11 10:22:40 CST 2025, time=2025-07-11, status=1, ipAttribution=陕西省)]

2024-11-06 ms1000001788822132 来自上海

审稿速度:1.0 | 投稿命中率:75.0
经验分享：速度挺快的，着急毕业的可以了解一下这个期刊。
7.29投稿
8.13给了一审意见
后面又修改了3次
10月5接收
耗时两个月多一点

76 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157282, encodeId=3631215e28241, content=偏重的研究方向：生物信息学;分子医学 经验分享：9.8投了篇纯生信，，，还是p e n d in g r ev i e w，要拒也麻烦快一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29968843690, createdName=ms4000000352004046, createdTime=Tue Sep 12 10:48:42 CST 2023, time=2023-09-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2262340, encodeId=1d80226234078, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤生信分析 经验分享：现在pending的时间是变长了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0578477592, createdName=ms7000000921712169, createdTime=Sat Apr 26 10:41:59 CST 2025, time=2025-04-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2288854, encodeId=0a242288854a5, content=中科院分区再这上面是2区top 再letpub上面是3区差的有点大啊哪个准确啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6bd22035102, createdName=六月的雨, createdTime=Fri Nov 14 10:55:31 CST 2025, time=2025-11-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2287414, encodeId=2c55228e4149a, content=请问WB按分子量裁开分别敷抗体然后拼接在一起，这样可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeea9862050, createdName=ms8000001548862053, createdTime=Tue Nov 04 08:47:56 CST 2025, time=2025-11-04, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2280825, encodeId=bf4722808259e, content=我投稿第二天就Pending editor decision，是不是要拒了，医院的，但是基本纯实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37235317227, createdName=1489e359m96(暂无昵称), createdTime=Thu Sep 11 08:15:35 CST 2025, time=2025-09-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2244137, encodeId=26d3224413e92, content=挺好的杂志，审稿很认真，也没有预警，值得一投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa371702984, createdName=malonglee, createdTime=Sat Dec 21 20:15:04 CST 2024, time=2024-12-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2235629, encodeId=2f592235629c7, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：速度挺快的，着急毕业的可以了解一下这个期刊。 7.29投稿 8.13给了一审意见 后面又修改了3次 10月5接收 耗时两个月多一点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822132, createdTime=Wed Nov 06 23:52:06 CST 2024, time=2024-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2259467, encodeId=a53c225946e16, content=偏重的研究方向：转化 经验分享：4月上旬投稿，记录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/392EF952E79DBD31432C86E1D99AF01C/100, createdBy=03d22194782, createdName=lssmd, createdTime=Mon Apr 07 17:21:28 CST 2025, time=2025-04-07, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2122268, encodeId=fb1f212226849, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：miRNA;生化 经验分享：我3.27提交大修返修稿在MDPI系统里一直提交不了，3.28号今天是最后一天，今天试了还是提交不了，我是7号收到的大修，给了10天，我申请延期至28号，编辑也同意了，昨天早上收到催我返修的邮件，昨天下午五点左右就开始尝试提交资料和返修稿子，但一直网站显示不行，不是网络的问题，也不是电脑的问题，真的傻了，现在还是提交不了，不知道咋整了，一直显示网站错误，我已经回复审稿人的意见和将我的修改的手稿和相关补充材料发给了编辑，和编辑说明了这个情况，希望编辑能够帮我将修改稿和相关资料发给审稿人，这样可以吗？因为暂时没有收到编辑的回复，有点担心⊙﹏⊙‖大家有遇到这样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b77e8515511, createdName=slbyzrbf, createdTime=Tue Mar 28 13:36:40 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2272906, encodeId=8f5422e290697, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：重金属的神经毒性;生信分析 经验分享：收稿日期 19 六月 2025 修订日期 7 七月 2025 录用日期 9 七月 2025 提交第一次决定（天） 18 提交发布（天） 修订轮次 1 这两天刚接收，编辑很积极，会经常发邮件提醒，节奏也很快，有2个审稿人，只有一次小修，总体很顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63949468110, createdName=ms7000000807282110, createdTime=Fri Jul 11 10:22:40 CST 2025, time=2025-07-11, status=1, ipAttribution=陕西省)]

2025-04-07 lssmd 来自黑龙江省

偏重的研究方向：转化
经验分享：4月上旬投稿，记录

83 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157282, encodeId=3631215e28241, content=偏重的研究方向：生物信息学;分子医学 经验分享：9.8投了篇纯生信，，，还是p e n d in g r ev i e w，要拒也麻烦快一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29968843690, createdName=ms4000000352004046, createdTime=Tue Sep 12 10:48:42 CST 2023, time=2023-09-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2262340, encodeId=1d80226234078, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤生信分析 经验分享：现在pending的时间是变长了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0578477592, createdName=ms7000000921712169, createdTime=Sat Apr 26 10:41:59 CST 2025, time=2025-04-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2288854, encodeId=0a242288854a5, content=中科院分区再这上面是2区top 再letpub上面是3区差的有点大啊哪个准确啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6bd22035102, createdName=六月的雨, createdTime=Fri Nov 14 10:55:31 CST 2025, time=2025-11-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2287414, encodeId=2c55228e4149a, content=请问WB按分子量裁开分别敷抗体然后拼接在一起，这样可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeea9862050, createdName=ms8000001548862053, createdTime=Tue Nov 04 08:47:56 CST 2025, time=2025-11-04, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2280825, encodeId=bf4722808259e, content=我投稿第二天就Pending editor decision，是不是要拒了，医院的，但是基本纯实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37235317227, createdName=1489e359m96(暂无昵称), createdTime=Thu Sep 11 08:15:35 CST 2025, time=2025-09-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2244137, encodeId=26d3224413e92, content=挺好的杂志，审稿很认真，也没有预警，值得一投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa371702984, createdName=malonglee, createdTime=Sat Dec 21 20:15:04 CST 2024, time=2024-12-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2235629, encodeId=2f592235629c7, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：速度挺快的，着急毕业的可以了解一下这个期刊。 7.29投稿 8.13给了一审意见 后面又修改了3次 10月5接收 耗时两个月多一点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822132, createdTime=Wed Nov 06 23:52:06 CST 2024, time=2024-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2259467, encodeId=a53c225946e16, content=偏重的研究方向：转化 经验分享：4月上旬投稿，记录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/392EF952E79DBD31432C86E1D99AF01C/100, createdBy=03d22194782, createdName=lssmd, createdTime=Mon Apr 07 17:21:28 CST 2025, time=2025-04-07, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2122268, encodeId=fb1f212226849, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：miRNA;生化 经验分享：我3.27提交大修返修稿在MDPI系统里一直提交不了，3.28号今天是最后一天，今天试了还是提交不了，我是7号收到的大修，给了10天，我申请延期至28号，编辑也同意了，昨天早上收到催我返修的邮件，昨天下午五点左右就开始尝试提交资料和返修稿子，但一直网站显示不行，不是网络的问题，也不是电脑的问题，真的傻了，现在还是提交不了，不知道咋整了，一直显示网站错误，我已经回复审稿人的意见和将我的修改的手稿和相关补充材料发给了编辑，和编辑说明了这个情况，希望编辑能够帮我将修改稿和相关资料发给审稿人，这样可以吗？因为暂时没有收到编辑的回复，有点担心⊙﹏⊙‖大家有遇到这样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b77e8515511, createdName=slbyzrbf, createdTime=Tue Mar 28 13:36:40 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2272906, encodeId=8f5422e290697, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：重金属的神经毒性;生信分析 经验分享：收稿日期 19 六月 2025 修订日期 7 七月 2025 录用日期 9 七月 2025 提交第一次决定（天） 18 提交发布（天） 修订轮次 1 这两天刚接收，编辑很积极，会经常发邮件提醒，节奏也很快，有2个审稿人，只有一次小修，总体很顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63949468110, createdName=ms7000000807282110, createdTime=Fri Jul 11 10:22:40 CST 2025, time=2025-07-11, status=1, ipAttribution=陕西省)]

2023-03-28 slbyzrbf 来自广东省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：miRNA;生化
经验分享：我3.27提交大修返修稿在MDPI系统里一直提交不了，3.28号今天是最后一天，今天试了还是提交不了，我是7号收到的大修，给了10天，我申请延期至28号，编辑也同意了，昨天早上收到催我返修的邮件，昨天下午五点左右就开始尝试提交资料和返修稿子，但一直网站显示不行，不是网络的问题，也不是电脑的问题，真的傻了，现在还是提交不了，不知道咋整了，一直显示网站错误，我已经回复审稿人的意见和将我的修改的手稿和相关补充材料发给了编辑，和编辑说明了这个情况，希望编辑能够帮我将修改稿和相关资料发给审稿人，这样可以吗？因为暂时没有收到编辑的回复，有点担心⊙﹏⊙‖大家有遇到这样情况的吗

211 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157282, encodeId=3631215e28241, content=偏重的研究方向：生物信息学;分子医学 经验分享：9.8投了篇纯生信，，，还是p e n d in g r ev i e w，要拒也麻烦快一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29968843690, createdName=ms4000000352004046, createdTime=Tue Sep 12 10:48:42 CST 2023, time=2023-09-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2262340, encodeId=1d80226234078, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤生信分析 经验分享：现在pending的时间是变长了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0578477592, createdName=ms7000000921712169, createdTime=Sat Apr 26 10:41:59 CST 2025, time=2025-04-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2288854, encodeId=0a242288854a5, content=中科院分区再这上面是2区top 再letpub上面是3区差的有点大啊哪个准确啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6bd22035102, createdName=六月的雨, createdTime=Fri Nov 14 10:55:31 CST 2025, time=2025-11-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2287414, encodeId=2c55228e4149a, content=请问WB按分子量裁开分别敷抗体然后拼接在一起，这样可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeea9862050, createdName=ms8000001548862053, createdTime=Tue Nov 04 08:47:56 CST 2025, time=2025-11-04, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2280825, encodeId=bf4722808259e, content=我投稿第二天就Pending editor decision，是不是要拒了，医院的，但是基本纯实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37235317227, createdName=1489e359m96(暂无昵称), createdTime=Thu Sep 11 08:15:35 CST 2025, time=2025-09-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2244137, encodeId=26d3224413e92, content=挺好的杂志，审稿很认真，也没有预警，值得一投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa371702984, createdName=malonglee, createdTime=Sat Dec 21 20:15:04 CST 2024, time=2024-12-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2235629, encodeId=2f592235629c7, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：速度挺快的，着急毕业的可以了解一下这个期刊。 7.29投稿 8.13给了一审意见 后面又修改了3次 10月5接收 耗时两个月多一点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822132, createdTime=Wed Nov 06 23:52:06 CST 2024, time=2024-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2259467, encodeId=a53c225946e16, content=偏重的研究方向：转化 经验分享：4月上旬投稿，记录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/392EF952E79DBD31432C86E1D99AF01C/100, createdBy=03d22194782, createdName=lssmd, createdTime=Mon Apr 07 17:21:28 CST 2025, time=2025-04-07, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2122268, encodeId=fb1f212226849, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：miRNA;生化 经验分享：我3.27提交大修返修稿在MDPI系统里一直提交不了，3.28号今天是最后一天，今天试了还是提交不了，我是7号收到的大修，给了10天，我申请延期至28号，编辑也同意了，昨天早上收到催我返修的邮件，昨天下午五点左右就开始尝试提交资料和返修稿子，但一直网站显示不行，不是网络的问题，也不是电脑的问题，真的傻了，现在还是提交不了，不知道咋整了，一直显示网站错误，我已经回复审稿人的意见和将我的修改的手稿和相关补充材料发给了编辑，和编辑说明了这个情况，希望编辑能够帮我将修改稿和相关资料发给审稿人，这样可以吗？因为暂时没有收到编辑的回复，有点担心⊙﹏⊙‖大家有遇到这样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b77e8515511, createdName=slbyzrbf, createdTime=Tue Mar 28 13:36:40 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2272906, encodeId=8f5422e290697, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：重金属的神经毒性;生信分析 经验分享：收稿日期 19 六月 2025 修订日期 7 七月 2025 录用日期 9 七月 2025 提交第一次决定（天） 18 提交发布（天） 修订轮次 1 这两天刚接收，编辑很积极，会经常发邮件提醒，节奏也很快，有2个审稿人，只有一次小修，总体很顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63949468110, createdName=ms7000000807282110, createdTime=Fri Jul 11 10:22:40 CST 2025, time=2025-07-11, status=1, ipAttribution=陕西省)]

2025-07-11 ms7000000807282110 来自陕西省

审稿速度:1.0 | 投稿命中率:95.0
偏重的研究方向：重金属的神经毒性;生信分析
经验分享：收稿日期 19 六月 2025
修订日期 7 七月 2025
录用日期 9 七月 2025
提交第一次决定（天） 18
提交发布（天）
修订轮次 1
这两天刚接收，编辑很积极，会经常发邮件提醒，节奏也很快，有2个审稿人，只有一次小修，总体很顺利

60 0 举报

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务